152 related articles for article (PubMed ID: 25060940)
1. Successful perioperative use of prothrombin complex concentrate in the treatment of acquired factor X deficiency in the setting of systemic light-chain (AL) amyloidosis.
Litvak A; Kumar A; Wong RJ; Smith L; Hassou H; Soff G
Am J Hematol; 2014 Dec; 89(12):1153-4. PubMed ID: 25060940
[No Abstract] [Full Text] [Related]
2. Multifocal papillary thyroid carcinoma associated with primary amyloid goiter.
Coca-Pelaz A; Vivanco-Allende B; Alvarez-Marcos C; Suarez-Nieto C
Auris Nasus Larynx; 2012 Oct; 39(5):549-51. PubMed ID: 22075140
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous major bleeding in acquired factor X deficiency secondary to AL-amyloidosis.
Enjeti AK; Walsh M; Seldon M
Haemophilia; 2005 Sep; 11(5):535-8. PubMed ID: 16128899
[TBL] [Abstract][Full Text] [Related]
4. Successful perioperative management of factor X deficiency associated with primary amyloidosis.
Takabe K; Holman PR; Herbst KD; Glass CA; Bouvet M
J Gastrointest Surg; 2004; 8(3):358-62. PubMed ID: 15019934
[TBL] [Abstract][Full Text] [Related]
5. Fatal bleeding due to acquired factor IX and X deficiency: a rare complication of primary amyloidosis; case report and review of the literature.
Ericson S; Shah N; Liberman J; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):e81-6. PubMed ID: 24290671
[No Abstract] [Full Text] [Related]
6. Prolongation of thrombin and reptilase times in patients with amyloidosis and acquired factor X deficiency.
Butler WM; Baldwin PE
South Med J; 1984 May; 77(5):648-51. PubMed ID: 6372111
[TBL] [Abstract][Full Text] [Related]
7. Importance of pharmacokinetic studies in the management of acquired factor X deficiency.
Lim MY; McCarthy T; Chen SL; Rollins-Raval MA; Ma AD
Eur J Haematol; 2016 Jan; 96(1):60-4. PubMed ID: 25782416
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency.
Guo YM; Takahashi N; Miyabe K; Yoshida M; Abe F; Yamashita T; Nara M; Yoshioka T; Ohashi K; Goto A; Takahashi N
Intern Med; 2019 Oct; 58(20):3039-3043. PubMed ID: 31243220
[TBL] [Abstract][Full Text] [Related]
9. Acquired factor X deficiency in light chain amyloidosis: a report of 2 Korean cases.
Ma Y; Kwon EH; Lee JE; Kim K; Kim HJ; Kim SH
Korean J Lab Med; 2011 Jul; 31(3):154-6. PubMed ID: 21779187
[TBL] [Abstract][Full Text] [Related]
10. Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced disease.
Patel G; Hari P; Szabo A; Rein L; Kreuziger LB; Chhabra S; Dhakal B; D'Souza A
Hematol Oncol Stem Cell Ther; 2019 Mar; 12(1):10-14. PubMed ID: 30879471
[TBL] [Abstract][Full Text] [Related]
11. Acquired Factor X Deficiency in Patients With Primary Light Chain Amyloidosis.
Dejhansathit S; Suvannasankha A
J Investig Med High Impact Case Rep; 2019; 7():2324709619832332. PubMed ID: 30947547
[TBL] [Abstract][Full Text] [Related]
12. Acquired factor X deficiency associated with atypical AL-amyloidosis.
Furuhata M; Doki N; Hishima T; Okamoto T; Koyama T; Kaito S; Oshikawa G; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Intern Med; 2014; 53(16):1841-5. PubMed ID: 25130122
[TBL] [Abstract][Full Text] [Related]
13. [Acquired factor X deficiency developed four years after autologous transplantation in a patient with multiple myeloma associated with systemic AL amyloidosis].
Takemura T; Fukatsu Y; Nagata Y; Asahina A; Yokota D; Hirano I; Yagyu T; Ono T; Katsumi A; Ohnishi K
Rinsho Ketsueki; 2014 May; 55(5):558-62. PubMed ID: 24881922
[TBL] [Abstract][Full Text] [Related]
14. Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis.
Mahmood S; Blundell J; Drebes A; Hawkins PN; Wechalekar AD
Blood; 2014 May; 123(18):2899-900. PubMed ID: 24786460
[No Abstract] [Full Text] [Related]
15. Acquired factor X deficiency in systemic amyloidosis.
Lucas FV; Fishleder AJ; Becker RC; Cavalier DS; Tubbs RR
Cleve Clin J Med; 1987; 54(5):399-406. PubMed ID: 3665021
[No Abstract] [Full Text] [Related]
16. [AL amyloidosis-associated factor X deficiency].
Croles FN; Beerenhout CH; Mulder AB; Meijer K; Nijziel MR
Ned Tijdschr Geneeskd; 2014; 158(6):A6678. PubMed ID: 24495369
[TBL] [Abstract][Full Text] [Related]
17. [Decreased Quick percentage, acquired factor X deficiency, hemarthrosis and ecchymosis: amyloidosis].
Bohler A; Lämmle B
Ther Umsch; 1999 Sep; 56(9):523-5. PubMed ID: 10517125
[TBL] [Abstract][Full Text] [Related]
18. Normalization of plasma factor X levels in amyloidosis after plasma exchange.
Beardell FV; Varma M; Martinez J
Am J Hematol; 1997 Jan; 54(1):68-71. PubMed ID: 8980263
[TBL] [Abstract][Full Text] [Related]
19. Isolated autonomic failure without evident somatic polyneuropathy in AL amyloidosis.
Sugiyama A; Asahina M; Takeda Y; Shiojiri T; Sano K; Ikeda S; Kuwabara S
Amyloid; 2014 Sep; 21(3):218-20. PubMed ID: 24970351
[No Abstract] [Full Text] [Related]
20. [Systemic light chain amyloidosis with acquired factor X deficiency: a case report].
Li L; Zhou F; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):506. PubMed ID: 22967401
[No Abstract] [Full Text] [Related]
[Next] [New Search]
